Results 21 to 30 of about 13,599 (199)

Exome Sequencing in Suspected Monogenic Dyslipidemias [PDF]

, 2015
Exome sequencing is a promising tool for gene mapping in Mendelian disorders.
Rich, Stephen S, Hovingh, G Kees, Boileau, Catherine, Shendure, Jay, Motazacker, M Mahdi, Kastelein, John JP, Haller, Jorge F, Mabuchi, Hiroshi, Risman, Marjorie, Nickerson, Deborah A, Abifadel, Marianne, Awan, Zuhier, Nohara, Atsushi, Tarugi, Patrizia, Kawashiri, Masa Aki, Neale, Benjamin M., Nickerson, Deborah A., Farlow, Deborah N., Deo, Rahul, Rader, Daniel J., Rader, Daniel J, Tada, Hayato, Daly, Mark J, Peloso, Gina M, Larach, Daniel B., Averna, Maurizio R, Kathiresan, Sekar, Rabès, Jean-Pierre, Peloso, Gina M., Neale, Benjamin M, Haller, Jorge F., Kastelein, John J. P., Wilson, James G, Wilson, James G., Varret, Mathilde, Yamagishi, Masakazu, Freeman, Mason W, Averna, Maurizio R., Pullinger, Clive R., Kane, John P., Cefalu, Angelo B, Genest, Jacques, Motazacker, M. Mahdi, Pullinger, Clive R, Fouchier, Sigrid, Ruel, Isabelle, Hovingh, G. Kees, Larach, Daniel B, Cefalù, Angelo B., Gabriel, Stacey, Farlow, Deborah N, Daly, Mark J., Kane, John P, Gupta, Namrata, Stitziel, Nathan O., Noto, Davide, Rich, Stephen S., Rabès, Jean Pierre, Kawashiri, Masa-Aki, Freeman, Mason W., Stitziel, Nathan O, TARUGI, Patrizia Maria   +61 more
core   +2 more sources

Genetics of Dyslipidemia

Arquivos Brasileiros de Cardiologia, 2016
Lipoproteins constitute a set of proteins and lipids, organized to facilitate the transport of lipids through blood plasma. Elevated or decreased levels of these lipoproteins may be related to genetic alterations in 40% to 60% of cases.1 This fact explains why it is common to find lipid abnormalities in several members of the same family.
García-Giustiniani, Diego, Stein, Ricardo   +1 more
openaire   +4 more sources

Treatment of dyslipidemia [PDF]

F1000Prime Reports, 2014
Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Tonkin, Andrew, Byrnes, Allison
openaire   +2 more sources

Adipose Tissue Complexities in Dyslipidemias

, 2019
Adipose tissue is the largest organ in the human body and, in excess, contributes to dyslipidemias and the dysregulation of other vascular and metabolic processes.
Deborah R. Gustafson, Gustafson, Deborah R., Gustafson, Deborah R.,   +2 more
core   +1 more source

Screening for Familial Hypercholesterolemia in Childhood: An Overview of Current Practices Around the World

Children
Familial hypercholesterolemia (FH) is a common genetic disorder with a fairly constant worldwide prevalence of 1 case per 311 individuals worldwide.
Maria Elena Capra, Roberta Sodero, Elisa Travaglia, Giuseppe Banderali, Giacomo Biasucci, Cristina Pederiva   +5 more
doaj   +1 more source

Evaluation of Lipid Profiles of Children and Youth from Basic Health Units in Campinas, SP, Brazil: A Cross-Sectional Laboratory Study [PDF]

Arquivos Brasileiros de Cardiologia
Background: Among dyslipidemias, hypercholesterolemia is considered the main risk factor for cardiovascular diseases in adults. In childhood and adolescence, elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are positively ...
Érica Ivana Lázaro Gomes, Vanessa Helena de Souza Zago, Eliana Cotta de Faria   +2 more
doaj   +3 more sources

Dyslipidemias associated with endocrine disorders: a position statement of the working group of the nutrition hormones and metabolism club of the italian society of endocrinology (SIE). [PDF]

J Endocrinol Invest
Purpose: Dyslipidemias are highly prevalent metabolic disturbances and represent a major driver of atherosclerotic cardiovascular disease. Beyond primary forms, numerous endocrine diseases induce secondary dyslipidemias that substantially modify lipid ...
Muscogiuri G, Albertelli M, Arnaldi G, Barrea L, Bellastella G, Bonomi M, Caputo M, Caprio M, Cignarelli A, Di Gioia L, Frasca F, Ferrari D, Gambineri A, Gasco V, Gatto F, Giandalia A, Giordano R, Infante M, Isidori A, Malandrino P, Occhi G, Pivonello R, Prencipe N, Prodam F, Simeoli C, Verde L, Vignozzi L, Cannavò S, Giorgino F, Colao A, Aimaretti G, Ferone D, Perrini S.   +32 more
europepmc   +2 more sources

Atherogenic dyslipidemia

Indian Journal of Endocrinology and Metabolism, 2013
Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, elevated levels of large TG rich very low-density lipoproteins, apolipoprotein B and oxidised low-density lipoprotein (LDL), and reduced ...
C N Manjunath, Jayesh R Rawal, Paurus Mehelli Irani, K Madhu   +3 more
openaire   +3 more sources

Dyslipidemias - modern understanding and management [PDF]

, 2015
Сърдечно-съдовите заболявания (ССЗ) са основна причина за смърт и инвалидност у нас и по света. За развитието им основно значение има нарушението в липидния метаболизъм, което води до атеросклероза на съдовете.
Yotov, Yoto; First Cardiology Clinic, St. Marina University Hospital, Varna, Sector of Cardiology and Rheumatology, Department of Internal Diseases, Medical University of Varna
core   +1 more source

Plant Sterols and Stanols for Pediatric Patients with Increased Cardiovascular Risk

Children
The atherosclerotic process begins in childhood and progresses throughout adult age. Hypercholesterolemia, especially familial hypercholesterolemia (FH) and metabolic dysfunctions linked to weight excess and obesity, are the main atherosclerosis risk ...
Cristina Pederiva, Giacomo Biasucci, Giuseppe Banderali, Maria Elena Capra   +3 more
doaj   +1 more source